MAPT and Alzheimer disease: First, depressive symptoms have been associated with impaired hippocampal neurogenesis (Kreisel et al., 2014), which may exacerbate neurodegenerative processes and accelerate the accumulation of toxic proteins in AD, including Aβ and tau.